Table 3 Clinical outcomes
Variables | Vildagliptin group (n = 10) | Control group (n = 10) | p Value |
|---|---|---|---|
Cardiac death, % | 0 | 0 | |
Myocardial infarction, % | 0 | 0 | |
Cerebral infarction, % | 0 | 0 | |
Target lesion revascularization, % | 0 | 10 | 1.000 |
Target vessel revascularization, % | 0 | 20 | 0.473 |